Image

Safety Evaluation Study for Patients With Polycythemia Vera

Safety Evaluation Study for Patients With Polycythemia Vera

Non Recruiting
20-75 years
All
Phase 1
  • Technical (Original)
  • Simplified (AI rewritten)

Powered by AI

Overview

This is PhaseI Dose-Escalation Study to Evaluate the Safety and Pharmacokinetics of PPMX-T003 in Polycythemia Vera

Eligibility

Inclusion Criteria:

  • Confirmed diagnosis of PV according to either the 2008 or 2016 WHO classification criteria
  • PV patients being only treated with phlebotomy and the interval is 4-9 weeks

Exclusion Criteria:

  • Patients administrated drugs for PV treatment such as hydroxyurea or ruxolitinib (aspirin is excluded)

Study details
    Polycythemia Vera

NCT05074550

Perseus Proteomics Inc.

20 August 2025

Contact a study center

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.